Option chain shows key data for Inhibitor Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Inhibitor Therapeutics.

Inhibitor Therapeutics (OTC:INTI) Stock, Option Chain

Inhibitor Therapeutics Inc is a pharmaceutical development company that is focused on developing and ultimately commercializing therapeutics based on already approved active pharmaceuticals that have patent-protected methods of use and/or methods of delivery for patients with certain cancers and certain non-cancerous proliferation disorders. The company's main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.

INHIBITOR THERAPTICS INC by Inhibitor Therapeutics Inc.

Inhibitor Therapeutics Inc

Health Care

Comments

Inhibitor Therapeutics

Inhibitor Therapeutics (INTI) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell